Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma

Cancer Science

Volumn 102, Issue 12, 2011, Pages 2164-2171

  Susuki, Dai ^a   Kimura, Sotai ^a   Naganuma, Seiji ^a   Tsuchiyama, Katsuki ^a   Tanaka, Toshiaki ^b   Kitamura, Naomi ^b   Fujieda, Shigeharu ^a   Itoh, Hiroshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GENE PRODUCT; MATRIPTASE; MICRORNA; PROTEIN TYROSINE KINASE; PROTEIN ZEB1; SCATTER FACTOR; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DEGRADATION; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION REGULATION; GENE TARGETING; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UPREGULATION; ZEB1 GENE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HEAD AND NECK NEOPLASMS; HEPATOCYTE GROWTH FACTOR; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SERINE ENDOPEPTIDASES; TRANSCRIPTION FACTORS;

EID: 81855194330     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02096.x     Document Type: Article

References (48)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-43.
2. Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22.
3. Tran N, Rose BR, O'Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck 2007; 29: 64-70.
4. Ohnishi T, Daikuhara Y. Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues. Arch Oral Biol 2003; 48: 797-804.
5. Uchida D, Kawamata H, Omotehara F et al. Role of HGF/c-MET system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer 2001; 93: 489-96.
6. Knowles LM, Stabile LP, Egloff AM et al. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer. Clin Cancer Res 2009; 15: 3740-50.
7. Morello S, Olivero M, Aimetti M et al. MET receptor is overexpressed but not mutated in oral squamous cell carcinoma. J Cell Physiol 2001; 189: 285-90.
8. Lagos-Quintana M, Rauhut R, Lendeckel T, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-8.
9. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
10. Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 2006; 289: 3-16.
11. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
12. Tamaru Y, Hayashizaki Y. Cancer research with non-coding RNA. Cancer Sci 2006; 97: 1285-90.
13. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8.
14. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
15. Inoue T, Kataoka H, Goto K et al. Activation of c-Met (hepatocyte growth factor receptor) in human gastric tissue. Cancer Sci 2004; 95: 803-8.
16. Gregory PA, Bert AG, Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
17. Wang Y, Rathinam R, Walch A, Alahari SK. ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem 2009; 284: 23094-106.
18. Bracken CP, Gregory PA, Kolesnikoff N et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008; 68: 7846-54.
19. Khraiwesh B, Arif MA, Seumel GI et al. Transcriptional control of gene expression by microRNAs. Cell 2010; 140: 111-22.
20. Tran N, McLean T, Zhang X et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007; 358: 12-7.
21. Ramdas L, Giri U, Ashorn C et al. miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck 2009; 31: 642-54.
22. Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009; 15: 2850-5.
23. Hui AB, Lenarduzzi M, Krushel T et al. Comprehensive microRNA profiling for head and neck squamous cell carcinoma. Clin Cancer Res 2010; 16: 1129-39.
24. Kimura S, Naganuma S, Susuki D et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010; 23: 1625-33.
25. Matsumoto K, Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 2006; 119: 477-83.
26. Ding W, You H, Dang H et al. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 2010; 52: 945-53.
27. Ren Y, Cao B, Law S et al. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res 2005; 11: 6190-7.
28. Dong G, Chen Z, Li ZY et al. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 2001; 61: 5911-8.
29. Hanzawa M, Shindoh M, Higashino F et al. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 2000; 21: 1079-85.
30. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010; 11: 252-63.
31. Migliore C, Petrelli A, Ghiso E et al. MicroRNAs impair MET-mediated invasive growth. Cancer Res 2008; 68: 10128-36.
32. Avraham R, Sas-Chen A, Manor O et al. EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors. Sci Signal 2010; 3: 43.
33. Santin AD, Cane S, Bellone S et al. The novel serine proteas tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma. Cancer 2003; 98: 1898-904.
34. Lee SL, Huang PY, Roller P et al. Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation. Mech Dev 2010; 127: 82-95.
35. Ding KF, Sun LF, Ge WT, Hu HG, Zhang SZ, Zheng S. Effect of SNC19/ST14 gene overexpression on invasion of colorectal cancer cells. World J Gastroenterol 2005; 11: 5651-4.
36. List K, Szabo R, Molinolo A et al. Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. Am J Pathol 2006; 168: 1513-25.
37. Johnson SM, Grosshans H, Shingara J et al. RAS is regulated by the let-7 microRNA family. Cell 2005; 120: 635-47.
38. Weidhaas JB, Babar I, Nallur SM et al. MicroRNA as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007; 67: 11111-6.
39. Hoa M, Davis SL, Ames SJ, Spanjaard RA. Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma. Cancer Res 2002; 62: 7154-6.
40. Calin GA, Dumitru CD, Shimizu M et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-9.
41. Cimmino A, Calin GA, Fabbri M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944-9.
42. Gao P, Tchernyshyov I, Chang TC et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009; 458: 762-5.
43. Mouillet JF, Chu T, Nelson DM, Mishima T, Sadovsky Y. MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J 2010; 24: 2030-9.
44. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 2007; 67: 11001-11.
45. Iorio MV, Casalini P, Piovan C et al. MicroRNA-205 regulates HER3 in human breast cancer. Cancer Res 2009; 69: 2195-200.
46. Childs G, Fazzari M, Kung G et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009; 174: 736-45.
47. Zidar N, Boštjančič E, Gale N et al. Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck - hallmark of epithelial-mesenchymal transition. Hum Pathol 2011; 42: 482-8.
48. Zhang H, Li M, Han Y et al. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 2010; 55: 2545-51.